Neoadjuvant Chemotherapy With Gemcitabine and S-1 Versus Upfront Surgery for Resectable Pancreatic Cancer: Results of the Randomized Phase II/III Prep-02/JSAP05 Trial.
第一作者:
Michiaki,Unno
第一单位:
Department of Surgery, Tohoku University Graduate School of Medicine, Sendai, Japan.
作者:
医学主题词
人类(Humans);喃氟啶(Tegafur);胰腺肿瘤(Pancreatic Neoplasms);氧嗪酸(Oxonic Acid);肿瘤辅助疗法(Neoadjuvant Therapy);脱氧胞苷(Deoxycytidine);女(雌)性(Female);男(雄)性(Male);复方合剂(Drug Combinations);中年人(Middle Aged);老年人(Aged);癌, 胰腺管(Carcinoma, Pancreatic Ductal);胰腺切除术(Pancreatectomy);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);抗代谢药, 抗肿瘤(Antimetabolites, Antineoplastic);成年人(Adult);治疗结果(Treatment Outcome);化学疗法, 辅助(Chemotherapy, Adjuvant);存活率(Survival Rate)
DOI
10.1097/SLA.0000000000006730
PMID
40235447
发布时间
2026-01-16
- 浏览0
Annals of surgery
57-64页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



